Last reviewed · How we verify

NCT05595291

Walking Characteristics of Patients With Amputation

Status unknown Last updated 19 January 2023
What this trial tests

trial testing investigation of the factors affecting walking characteristics in Amputation in 100 participants. Status unknown.

Timeline
5 February 2023
Primary endpoint
15 February 2023
15 February 2023

Quick facts

Lead sponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date5 February 2023
Primary completion15 February 2023
Estimated completion15 February 2023

Drugs / interventions tested

Conditions studied

Sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Who can join

Adults 18 to 65, male only, with Amputation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of the study is to reveal the early and late changes in the walking characteristics of patients with lower extremity amputation. Secondly, it is planned to reveal the factors affecting the walking characteristics of patients with amputation and to compare individuals with different levels of amputation in terms of clinical outcome measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Amputation

Currently open trials in the same condition.

Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05595291.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing